Stockscreener 앱 받기
6.07
6.68%
0.38
시간 외 거래:
5.95
-0.12
-1.98%
Coya Therapeutics Inc 주식(COYA)의 최신 뉴스
What analysts say about Coya Therapeutics Inc. stockAccelerated profit realization - Autocar Professional
What drives Coya Therapeutics Inc. stock priceTriple-digit return opportunities - Autocar Professional
Rh shares rise 1.14% premarket after Coya Therapeutics to participate in the BTIG Virtual Biotechnology Conference. - AInvest
Coya Therapeutics Inc. Stock Analysis and ForecastBreakout stock performance - jammulinksnews.com
Is Coya Therapeutics Inc. a good long term investmentFree Wealth Management Insights - jammulinksnews.com
Why Coya Therapeutics Inc. stock attracts strong analyst attentionMomentum Swing Watchlist - Newser
Coya Therapeutics shares rise 4.67% premarket after announcing participation in the BTIG Virtual Biotechnology Conference. - AInvest
Coya Therapeutics to Participate in BTIG Virtual Biotechnology Conference - AInvest
Coya Therapeutics to Participate in the BTIG Virtual Biotechnology Conference July 29 – 30, 2025 - Business Wire
(COYA) Investment Report - news.stocktradersdaily.com
What drives BENFW stock priceConsistent double returns - jammulinksnews.com
What makes Coya Therapeutics Inc. stock price move sharplyLow Risk Trade Timing Signals - Newser
How Coya Therapeutics Inc. stock performs during market volatilityFree Stock Selection with 300% Return - Newser
Coya Therapeutics (NASDAQ:COYA) Coverage Initiated at Lake Street Capital - Defense World
Coya Therapeutics initiated with a Buy at Lake Street - TipRanks
Coya Therapeutics stock initiated with Buy rating at Lake Street Capital - Investing.com UK
With CAR Ts and islets raising the bar in I&I, what’s the play for Tregs? - biocentury.com
Positive Outlook for Coya Therapeutics, Inc. Driven by IND Resubmission and Promising Trial Results - TipRanks
Coya Therapeutics (COYA) Receives Continued Buy Rating from Analyst | COYA Stock News - GuruFocus
Coya Therapeutics resubmits IND application for ALS Phase 2 study to FDA - Investing.com
Coya Therapeutics Holds Annual Stockholders Meeting - TipRanks
After myriad failures, a new wave of ALS drugs approaches - Pharma Voice
Coya Therapeutics to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24 – 25, 2025 - Business Wire
Trading (COYA) With Integrated Risk Controls - news.stocktradersdaily.com
4.91%
0.25%
자본화:
|
볼륨(24시간):